Showing results (1-10 of 141) with videos related to
Sort By:
Pageof 15
Oncoimmunology|May 8, 2015
Author's view: radiation and immunotherapy as systemic therapy for solid tumorsSteven N Seyedin, Chad Tang, James W WelshSeminars in Radiation Oncology|June 16, 2024
Is Single-Site Radiation Therapy Enough to Augment the Immune System and Enhance Immunotherapy for Metastatic Disease?Vivek Verma, Hampartsoum B Barsoumian, James W WelshInternational Review of Cell and Molecular Biology|February 5, 2019
Glycosylation and Antitumor ImmunityAlexandra P Cadena, Taylor R Cushman, James W WelshBalkan Medical Journal|February 11, 2015
Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung CancerUğur Selek, Yasemin Bölükbaşı, James W Welsh, et al.Advances in Radiation Oncology|October 30, 2018
Toxicity of radiation and immunotherapy combinationsVivek Verma, Taylor R Cushman, Chad Tang, et al.Immunotherapy|August 4, 2018
Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapyTaylor R Cushman, Mauricio S Caetano, James W Welsh, et al.Cancer|December 12, 2013
Progress in the management of limited-stage small cell lung cancerArya Amini, Lauren A Byers, James W Welsh, et al.International Journal of Radiation Oncology, Biology, Physics|July 18, 2018
Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II TrialsVivek Verma, Taylor R Cushman, Ugur Selek, et al.Radiation Oncology (London, England)|December 24, 2009
The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cellsJames W Welsh, Daruka Mahadevan, Ron Ellsworth, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Galectin-1 and immune suppression during radiotherapyJames W Welsh, Steven N Seyedin, Maria Angelica Cortez, et al.Pageof 15